Clinical Trial Detail

NCT ID NCT02400814
Title MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors University of California, Davis
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: adult

Additional content available in CKB BOOST